Eastwood Bio Medical Canada Stock Last Dividend Paid
EBM Stock | CAD 0.75 0.05 6.25% |
Eastwood Bio Medical Canada fundamentals help investors to digest information that contributes to Eastwood Bio-Medical's financial success or failures. It also enables traders to predict the movement of Eastwood Stock. The fundamental analysis module provides a way to measure Eastwood Bio-Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastwood Bio-Medical stock.
Eastwood | Last Dividend Paid |
Eastwood Bio Medical Canada Company Last Dividend Paid Analysis
Eastwood Bio-Medical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Eastwood Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Eastwood Bio-Medical is extremely important. It helps to project a fair market value of Eastwood Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Eastwood Bio-Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Eastwood Bio-Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Eastwood Bio-Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Eastwood Dividend Paid And Capex Coverage Ratio
Dividend Paid And Capex Coverage Ratio |
|
Based on the recorded statements, Eastwood Bio Medical Canada has a Last Dividend Paid of 0.0. This indicator is about the same for the Consumer Staples Distribution & Retail average (which is currently at 0.0) sector and about the same as Consumer Staples (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Eastwood Bio-Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Eastwood Bio-Medical from analyzing Eastwood Bio-Medical's financial statements. These drivers represent accounts that assess Eastwood Bio-Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Eastwood Bio-Medical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 78.2M | 84.1M | 82.7M | 114.7M | 103.2M | 79.5M | |
Enterprise Value | 78.1M | 84.1M | 82.7M | 114.7M | 103.2M | 78.8M |
Eastwood Fundamentals
Return On Equity | -7.47 | ||||
Return On Asset | -0.64 | ||||
Profit Margin | (0.74) % | ||||
Operating Margin | (0.51) % | ||||
Current Valuation | 51.72 M | ||||
Shares Outstanding | 68.89 M | ||||
Shares Owned By Insiders | 69.55 % | ||||
Number Of Shares Shorted | 63 | ||||
Price To Earning | (11.43) X | ||||
Price To Book | 2,943 X | ||||
Price To Sales | 79.05 X | ||||
Revenue | 867.94 K | ||||
Gross Profit | 902.74 K | ||||
EBITDA | (398.19 K) | ||||
Net Income | (546.6 K) | ||||
Cash And Equivalents | 708.26 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 23.08 K | ||||
Current Ratio | 3.42 X | ||||
Book Value Per Share | (0.02) X | ||||
Cash Flow From Operations | (16.89 K) | ||||
Short Ratio | 0.05 X | ||||
Earnings Per Share | (0.01) X | ||||
Beta | 0.28 | ||||
Market Capitalization | 51.66 M | ||||
Total Asset | 489.14 K | ||||
Retained Earnings | (5.54 M) | ||||
Working Capital | (1.18 M) | ||||
Net Asset | 489.14 K |
About Eastwood Bio-Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastwood Bio Medical Canada's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastwood Bio-Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastwood Bio Medical Canada based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.